CYFRA 21-1 presented a higher diagnostic capacity compared with either CA19-9 or CEA and positively correlated with tumor stage, representing an independent predictor of reduced recurrence-free and overall survival [75,76]. This evidence concerns the gene CEACAM5 and neoplasm.